Skip to content
Friday, March 24, 2023
HealthCare Middle East & Africa Logo 500

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
  • THE MAGAZINE
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • UAE-based AstraGene and Mylab form joint venture to commercialize automated diagnostics
  • Chinese missionaries in Rwanda perform painless normal delivery
  • <strong>OSHCO, VAMED Group to establish a new rehabilitation & long-term care hospital in Riyadh</strong>
  • Uganda launches project to scale up paediatric surgical services in hospitals
  • <strong>Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care</strong>
  • Macra supports Ministry of Health with US$53,296 cholera materials
  • KFSH&RC to debut its Digital Health Conference in Riyadh
  • NPHCDA launches project to prevent maternal health challenges
  • <strong>Saudi’s KAEC inks health cooperation pact with Dr. Sulaiman Al Habib Medical Group</strong>
  • Africa has the highest global surge in oral diseases - WHO
You are here
  • Home
  • AstraZeneca

Tag: AstraZeneca

FDA advisory panel to assess broader application of Merck-AstraZeneca cancer medication

5 March 20236 March 2023

USA —Merck & Co Inc and AstraZeneca have announced that an independent committee of advisers to the U.S. Food and Drug Administration (FDA) will evaluate their application for the expanded…

Read More

AstraZeneca debuts its rare disease drug Selumetinib for patients in India

1 March 20231 March 2023

INDIA – AstraZeneca India has introduced its rare disease drug Selumetinib for patients in India following regulatory approval, marking its entry into rare disease therapy in the country. AstraZeneca India,…

Read More

AstraZeneca’s Durvalumab nabs CDSCO approval for treating biliary tract cancer

18 February 202318 February 2023

INDIA – AstraZeneca India has received the go-ahead from Central Drugs Standard Control Organization (CDSCO) to market its drug Durvalumab for biliary tract cancer (BTC) treatment in India. The science-led…

Read More

FDA revokes authorization for AstraZeneca’s Covid antibody drug Evusheld citing ineffectiveness

29 January 202330 January 2023

USA — Evusheld, a preventative monoclonal antibody treatment for COVID-19, has lost its emergency use authorization in the United States because it is unlikely to be effective against the coronavirus…

Read More

AstraZeneca strengthens its cardiorenal pipeline with US$1.8B buyout deal of Cincor Pharma

15 January 202315 January 2023

USA— AstraZeneca has struck a deal to buy US-based biopharmaceutical firm CinCor Pharma Inc for up to US$1.8 billion to strengthen its pipeline of heart and kidney drugs and grow…

Read More

AstraZeneca to discontinue Leukemia drug Lumoxiti in the US market

13 January 202313 January 2023

USA— According to a recent Food and Drug Administration (FDA) communication, Lumoxiti for injection will be permanently discontinued in the US market by August 31, 2023. The FDA approved Lumoxiti,…

Read More

Pharma companies AstraZeneca & Pfizer reiterate focus on sustainability

7 January 20239 January 2023

AFRICA – Pharma giants AstraZeneca and Pfizer have reiterated their focus on sustainability with their on-going carbon footprint funding. AstraZeneca has set scope 1 and 2 target featuring carbon emissions…

Read More

AstraZeneca, G42 Healthcare ink deal to develop innovate drugs in Abu Dhabi

21 December 202221 December 2022

UAE – Biopharma giant AstraZeneca and G42 Healthcare, an AI-powered healthcare company, have teamed up to locally manufacture innovative drugs in the Emirate of Abu Dhabi. The strategic partnership deal…

Read More

AstraZeneca set to improve liver cancer understanding and care with new research center in Africa

16 December 202216 December 2022

AFRICA – AstraZeneca is set to establish a new liver cancer research partnership in countries in Africa to accelerate improved understanding and care for a form of liver cancer. In…

Read More

AstraZeneca Pharma India hires Dr. Sanjeev Panchal as Country President, MD

15 December 202216 December 2022

INDIA – AstraZeneca Pharma India Ltd. has appointed Dr. Sanjeev Panchal as Country President and Managing Director for a three-year term beginning January 1, 2023. He succeeds Gagandeep Singh Bedi,…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

LATEST NEWS

  • UAE-based AstraGene and Mylab form joint venture to commercialize automated diagnostics
  • Chinese missionaries in Rwanda perform painless normal delivery
  • OSHCO, VAMED Group to establish a new rehabilitation & long-term care hospital in Riyadh
  • Uganda launches project to scale up paediatric surgical services in hospitals
  • Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Japan Johnson & Johnson Kenya Malaria Merck Mergers, Investments & Funding Middle East and North Africa Moderna MOH Kenya Nigeria Novartis Partnerships Pfizer Pharmaceuticals Public Health Roche Science & Technology South Africa Switzerland Tanzania UAE Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa

Food Business Africa

Food Safety Africa

Milling & Baking Africa

Sustainable Packaging Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.